November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
June 3, 2026 - 19:22
Longmont City Council reviews proposal for technology advisory boardA proposal to create a technology advisory board in Longmont sparked a focused debate Tuesday night, with the central question being whether a member of the Youth Council should hold a voting seat...
June 3, 2026 - 04:52
Is Cognizant Technology Solutions Corporation (CTSH) Among the Most Undervalued Tech Stocks to Buy?Cognizant Technology Solutions Corporation (NASDAQ:CTSH) is gaining attention as one of the most undervalued stocks in the technology sector. On May 29, the company announced it is opening its...
June 2, 2026 - 12:32
New portable PET technology guides procedures with real-time imagingA new portable PET imaging system is changing how doctors perform interventional procedures by delivering high-quality scans at the point of care. Unlike traditional PET scanners that require...
June 1, 2026 - 18:19
FCC’s Office of Engineering and Technology Names New Lab ChiefThe Federal Communications Commission has appointed Cliff Jones as the new Associate Chief and Chief of the Laboratory Division within the Office of Engineering and Technology. Jones will oversee...